Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial
- Posted on May 6, 2026
- By Bing News
- 0 Views
- 1 min read
Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial
By Sneha S K May 6 (Reuters) - Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged 50 and older, researchers reported on Wednesday. The vaccine is currently under review by the U.S. Food and Drug Administration after the agency rejected the company's initial application. A decision is expected by
